KMT2A and leukemia: Delayed initiation of FF‐10501‐01 (from Day 12 to Day 23) still prolonged the survival of MLL‐AF9 leukemia mice, with reduction of GFP+ leukemia cells in peripheral blood (Fig EV3A and B).